|
RNF167 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.36429806025285E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76319958633542E-10 |
| Normal-vs-Stage2 |
1.645600E-02 |
| Normal-vs-Stage3 |
1.703740E-03 |
| Normal-vs-Stage4 |
2.963000E-01 |
| Stage1-vs-Stage2 |
4.425800E-01 |
| Stage1-vs-Stage3 |
7.616000E-01 |
| Stage1-vs-Stage4 |
3.776200E-01 |
| Stage2-vs-Stage3 |
6.869200E-01 |
| Stage2-vs-Stage4 |
8.028200E-01 |
| Stage3-vs-Stage4 |
5.834000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.23160420434965E-11 |
| Normal-vs-AfricanAmerican |
2.99650000001872E-06 |
| Normal-vs-Asian |
2.877000E-01 |
| Caucasian-vs-AfricanAmerican |
1.292960E-01 |
| Caucasian-vs-Asian |
9.803400E-01 |
| AfricanAmerican-vs-Asian |
7.968000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04000030809459E-10 |
| Normal-vs-Female |
1.64864999999681E-05 |
| Male-vs-Female |
6.657600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.583300E-03 |
| Normal-vs-Extreme_Weight |
3.40669999987497E-07 |
| Normal-vs-Obese |
9.93810000959883E-09 |
| Normal-vs-Extreme_Obese |
5.632500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.991200E-01 |
| Normal_Weight-vs-Obese |
4.978600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.410200E-01 |
| Extreme_Weight-vs-Obese |
4.219200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.063600E-01 |
| Obese-vs-Extreme_Obese |
6.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.590900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.20479984164501E-10 |
| Normal-vs-Age(61-80Yrs) |
3.27470000005547E-08 |
| Normal-vs-Age(81-100Yrs) |
9.503400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.378840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.139200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.435000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.008830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.996800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.464320E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63069557856943E-12 |
| Normal-VS-Type2 PRCC |
2.274500E-02 |
| Normal-VS-KIRP CIMP |
5.397900E-02 |
| Normal-VS-Unclassified PRCC |
1.315260E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.24389999997832E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.746800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.627380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.923610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.217600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.364800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.444500E-04 |
| Normal-vs-N1 |
8.723700E-03 |
| Normal-vs-N2 |
4.737600E-01 |
| N0-vs-N1 |
8.692200E-01 |
| N0-vs-N2 |
1.899210E-01 |
| N1-vs-N2 |
1.461980E-01 |
|
|
